These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24531086)

  • 1. Renal and vascular protective effects of ezetimibe in chronic kidney disease.
    Morita T; Morimoto S; Nakano C; Kubo R; Okuno Y; Seo M; Someya K; Nakahigashi M; Ueda H; Toyoda N; Kusabe M; Jo F; Takahashi N; Iwasaka T; Shiojima I
    Intern Med; 2014; 53(4):307-14. PubMed ID: 24531086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy and adverse effects of the addition of ezetimibe to statin versus statin titration in chronic kidney disease patients.
    Suzuki H; Watanabe Y; Kumagai H; Shuto H
    Ther Adv Cardiovasc Dis; 2013 Dec; 7(6):306-15. PubMed ID: 24280596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezetimibe therapy for dyslipidemia: an update.
    Katsiki N; Theocharidou E; Karagiannis A; Athyros VG; Mikhailidis DP
    Curr Pharm Des; 2013; 19(17):3107-14. PubMed ID: 23317398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of atorvastatin and ezetimibe on endothelial function in dyslipidemic patients with chronic kidney disease.
    Ishimitsu T; Ohno E; Ueno Y; Onoda S; Nagase A; Ohira T; Nakano N; Satonaka H
    Clin Exp Nephrol; 2014 Oct; 18(5):704-10. PubMed ID: 24198051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An observational study of ezetimibe in cardiac transplant recipients receiving calcineurin inhibitors.
    Makkar KM; Sanoski CA; Goldberg LR; Spinler SA
    Ann Pharmacother; 2013 Nov; 47(11):1457-62. PubMed ID: 24285762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant.
    Ahmed MH; Khalil AA
    Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1021-9. PubMed ID: 21060168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.
    Lamprea-Montealegre JA; Staplin N; Herrington WG; Haynes R; Emberson J; Baigent C; de Boer IH;
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):47-60. PubMed ID: 31831577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Kastelein JJ; Akdim F; Stroes ES; Zwinderman AH; Bots ML; Stalenhoef AF; Visseren FL; Sijbrands EJ; Trip MD; Stein EA; Gaudet D; Duivenvoorden R; Veltri EP; Marais AD; de Groot E;
    N Engl J Med; 2008 Apr; 358(14):1431-43. PubMed ID: 18376000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ezetimibe on remnant-like particle cholesterol, lipoprotein (a), and oxidized low-density lipoprotein in patients with dyslipidemia.
    Nozue T; Michishita I; Mizuguchi I
    J Atheroscler Thromb; 2010 Feb; 17(1):37-44. PubMed ID: 20075599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-administration of ezetimibe enhances proteinuria-lowering effects of pitavastatin in chronic kidney disease patients partly via a cholesterol-independent manner.
    Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Ueda Y; Suzuki T; Ueda S; Fukami K; Okuda S; Yamagishi S
    Pharmacol Res; 2010 Jan; 61(1):58-61. PubMed ID: 19666118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
    Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of ezetimibe added to statin therapy in patients with primary dyslipidaemia not achieving the LDL-C treatment goal on statin monotherapy.
    González CA; Rubio-Guerra AF; Pavía A; Redding FJ; Cervantes JL; Zacarías JL; Yza R; Carranza J; Fernández P; Morales E; Robles FJ; Leyva JL; Rodríguez L
    Clin Drug Investig; 2007; 27(5):333-7. PubMed ID: 17451281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical progression of atherosclerosis related to low-density lipoprotein reduction and exposure to ezetimibe.
    Taylor AJ; Villines TC; Stanek EJ
    Eur Heart J; 2012 Dec; 33(23):2939-45. PubMed ID: 22564353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of adding ezetimibe to fluvastatin on kidney function in patients with hypercholesterolemia: a randomized control trial.
    Kinouchi K; Ichihara A; Bokuda K; Morimoto S; Itoh H
    J Atheroscler Thromb; 2013; 20(3):245-56. PubMed ID: 23197250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
    Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
    J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of ezetimibe on LDL-cholesterol: quantitative or qualitative changes?
    Rizzo M; Rini GB; Spinas GA; Berneis K
    Atherosclerosis; 2009 Jun; 204(2):330-3. PubMed ID: 19027905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia.
    Ohsawa M; Tamura K; Wakui H; Kanaoka T; Azushima K; Uneda K; Haku S; Kobayashi R; Ohki K; Haruhara K; Kinguchi S; Toya Y; Umemura S
    Lipids Health Dis; 2015 Dec; 14():161. PubMed ID: 26645467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of adding ezetimibe to rosuvastatin on renal function in patients undergoing elective vascular surgery.
    Kouvelos GN; Arnaoutoglou EM; Milionis HJ; Raikou VD; Papa N; Matsagkas MI
    Angiology; 2015 Feb; 66(2):128-35. PubMed ID: 24458801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of ezetimibe and low-dose simvastatin as primary treatment for dyslipidemia in peritoneal dialysis patients.
    Suzuki H; Inoue T; Watanabe Y; Kikuta T; Sato T; Tsuda M
    Adv Perit Dial; 2010; 26():53-7. PubMed ID: 21348380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.